Clinical trial
Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy…
NCT00411125 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00411125 |
|---|---|
| Title | Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women |
| Official title | A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled Crossover Phase I Study Assessing Pharmacokinetics and Pharmacodynamics of Two Different SMC021 0.8 mg Variants and the Effect of Timing of Drug Intake in Healthy Postmenopausal Women |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Postmenopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | Oral salmon calcitonin |
| Enrollment | 86 |
| Start date | Aug 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 13, 2006 |
| Last update posted | Dec 13, 2006 |
| Countries | Denmark |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: